Registers as the basis for data collection and evidence building
Author:
Open Access
- 3 August 2021
- journal article
- research article
- Published by Publishing House OKI in Real-World Data & Evidence
- Vol. 1 (1) , 10-15
Abstract
The development of medical science requires a constant increase in the effectiveness and safety of treatment. Collection of real-world data (RWD) is one way of solving these problems. Clinical registries are one of the most important parts of this process. Clinical registries allow collecting data on the use of medical technologies and monitoring the results of therapy in real clinical practice. The introduction of patient registers and the collection of RWD data into widespread medical practice can help to optimize costs in the treatment of high-cost diseases and to better plan the budget.Keywords
This publication has 6 references indexed in Scilit:
- Diabetes epidemiology in Russia: what has changed over the decade?Terapevticheskii arkhiv, 2019
- Patient registers and account registries of compulsory medical insurance: integration and replaceabilityFARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology, 2019
- THU0305 Minimal disease activity (MDA) attainment after starting biological (B) dmards and non-bdmards treatment in psoriatic arthritis patients (PTS) in routine care: russian psoriatic arthritis registry (RU-PSART) dataAnnals of the Rheumatic Diseases, 2018
- REGISTERS IN CARDIOLOGY: THEIR PRINCIPLES, RULES, AND REAL-WORD POTENTIALCardiovascular Therapy and Prevention, 2013
- TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern SwedenAnnals of the Rheumatic Diseases, 2004
- Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern SwedenAnnals of the Rheumatic Diseases, 2002